Hans Bohn

TL;DR: It is proposed that placenta-specific galectins reduce the danger of maternal immune attacks on the fetal semiallograft, presumably conferring additional immune tolerance mechanisms and in turn sustaining hemochorial placentation during the long gestation of anthropoid primates.

TL;DR: In this paper, a placenta-derived galectin-13 (PP13) was cloned from human term placentia and a specific monoclonal antibody to PP13 was developed, which showed its conserved structural and functional homology to members of the Galectin family.

TL;DR: Expression of placental tissue protein 13 (PP13) in different human tissues was investigated by chemiluminescence Western blot analysis using monospecific anti-PP13 serum and Lysophospholipase activity of PP13 was confirmed by NMR measurements.

TL;DR: Computational results provide some new insights into the possible role and importance of PP13 in various processes of the human body and can be of help in the initial steps of further functional research.

TL;DR: A cDNA library prepared from human placenta was screened for sequences encoding the placental protein 4 (PP4), an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade.